N
Market Data
$35.26+$5.93 (+20.22%)
NAMS · Last trade
Prev Close
$29.33
Range (29d)
$29.83 – $36.99
Recent Filings
- 8-K465.7 KBNewAmsterdam Pharma Co N.V.Jun 3, 7:58 AM ET·0001193125-26-254615
- 1445.0 KBNewAmsterdam Pharma Co N.V.May 26, 5:04 PM ET·0001968582-26-000491
- 8-K714.3 KBNewAmsterdam Pharma Co N.V.May 7, 7:02 AM ET·0001193125-26-210283
- 10-Q7.5 MBNewAmsterdam Pharma Co N.V.May 7, 7:00 AM ET·0001193125-26-210272
- 8-K202.7 KBNewAmsterdam Pharma Co N.V.Apr 24, 4:30 PM ET·0001193125-26-177406
- 8-K18.5 MBNewAmsterdam Pharma Co N.V.Mar 2, 8:00 AM ET·0001193125-26-084266
- 10-K18.4 MBNewAmsterdam Pharma Co N.V.Feb 18, 7:00 AM ET·0001193125-26-056029
- 8-K862.0 KBNewAmsterdam Pharma Co N.V.Feb 18, 7:00 AM ET·0001193125-26-056020
- 8-K269.8 KBNewAmsterdam Pharma Co N.V.Jan 9, 8:00 AM ET·0001193125-26-008300
- 10-Q9.5 MBNewAmsterdam Pharma Co N.V.Nov 5, 8:00 AM ET·0001193125-25-265796
Insiders
10- Audet Juliette BerangereSee Remarks
- BCIP Life Sciences Associates, LP10% Owner
- BCLS Fund III Investments, LP10% Owner
- BCLS II Investco, LP10% Owner
- Bain Capital Life Sciences Fund II, L.P.10% Owner
- Bain Capital Life Sciences Fund III, L.P.10% Owner
- Bain Capital Life Sciences Investors, LLC10% Owner
- Davidson Michael H.Director, Chief Executive Officer
- Downing NicholasDirector
- Forbion Capital Fund IV Cooperatief U.A.10% Owner
Tickers
Addresses
business
GOOIMEER 2-35
NARRDEN, P7, 1411 DC
mailing
GOOIMEER 2-35
NARRDEN, P7, 1411 DC
Former Names
- NewAmsterdam Pharma Co B.V.2022-11-22